Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City

NEW YORK, NY / ACCESSWIRE / September 5, 2019 / Crescita Therapeutics Inc. (TSX:CTX)(OTC Pink:CRRTF) (Crescita or the Company), a Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today announced that its executive chairman, Dan Chicoine will be presenting at this year’s Fall Investor Summit on Monday, September 16th at 1:00 p.m. eastern time in New York City. Mr. Chicoine accompanied by Ms. Linda Kisa, Crescita’s director of investor relations, will also be meeting with investors one-on-one during the event.

The Fall Investor Summit will take place at the Essex House, featuring 160 companies and over 1,000 institutional and retail investors.

About Crescita Therapeutics Inc.

Crescita (TSX:CTX) (OTC Pink:CRRTF) is a publicly traded, Canadian commercial dermatology company with manufacturing capabilities and a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. Crescita owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active drugs into or through the skin. Please visit www.crescitatherapeutics.com for additional information.

About The Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting small cap and microcap companies with qualified investors.
To register as a presenting company: please contact Cassandra Miller (cassandra@microcapconf.com)
To request complimentary investor registration: please visit our website at www.microcapconf.com

FOR MORE INFORMATION

Please visit: www.microcapconf.com
Or, contact Ashley Allard at ashley@microcapconf.com

Investor Relations
Email: ir@crescitatx.com

Or

Glen Akselrod
Bristol Capital
Tel: 1-905-326-1888, extension 10
Email: glen@bristolir.com

News Compliments of ACCESSWIRE

SOURCE: Crescita Therapeautics Inc.

View source version on accesswire.com:
https://www.accesswire.com/558538/Crescita-Therapeutics-Inc-to-Present-at-the-Fall-Investor-Summit-on-September-16th-17th-in-New-York-City

Staff

Recent Posts

remedi Expands Waste Tracking and Reporting to Support Hospital Sustainability and Procurement Teams

Enhanced visibility helps healthcare systems measure landfill diversion, compliance, and operational performanceSAN ANTONIO, Jan. 29,…

4 hours ago

School-Reported Reading Assessments Show Atypical Gains for Students With Dyslexia

NWEA MAP®, STAR®, aReading, AUTOreading, and WIST Results Reflect Gains in Reading and Language SkillsJACKSONVILLE,…

4 hours ago

Zivian Health Announces Leadership Transition as Co-Founder Rafid Fadul, MD, Joins ARPA-H; Griffin Mulcahey Named CEO

WASHINGTON, Jan. 29, 2026 /PRNewswire/ -- Zivian Health, the healthcare workforce technology company, today announced…

10 hours ago

Dental Industry Veteran Mart Goldberg Develops Patented Multi-Material 3D Printing Technology, Poised to Transform Prosthetics Manufacturing

LOS ANGELES, Jan. 29, 2026 /PRNewswire/ -- After more than 25 years owning and operating dental…

10 hours ago

CAQH Appoints Melissa Frieswick as Chief Commercial Officer

Marking a new phase of growth as CAQH strengthens how it works with providers, health…

10 hours ago

Medely Introduces Workforce Orchestration, Redefining How Healthcare Systems Manage Clinical Labor

LOS ANGELES, Jan. 29, 2026 /PRNewswire/ -- Today, Medely announced the launch of its workforce orchestration…

10 hours ago